
Merck and The Michael J. Fox Foundation Launch Service to Propel Parkinson’s Research Forward
Merck and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) are collaborating to advance research aimed at slowing the progression of Parkinson’s disease (PD). Funded by MJFF’s “Biomarkers to Support Therapeutic Trials Program,” Merck’s SMCxPRO® immunoassay technology has been…











